Linda Burkly, EVP, CHIEF SCIENTIFIC OFFICER at Editas Medicine, Inc. (EDIT), sold 709 shares at $3.04 ($2K) on 2026-09-03, disclosed to the SEC on 2026-09-04.
Open-market sale of $2k EDIT by EVP, CHIEF SCIENTIFIC OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| EDIT | SELL | 2026-03-04 | $2K | — | Filing → |
| EDIT | SELL | 2025-12-04 | $2K | — | Filing → |
| EDIT | SELL | 2025-09-04 | $2K | — | Filing → |